glyoxal has been researched along with angiotensin ii in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boucher, J; Froehlich, U; Grandbois, M; Simard, E | 1 |
| Caroccia, B; Hanssen, NMJ; Piazza, M; Rossi, GP; Schalkwijk, CG; Scheijen, JLJM; Seccia, TM; Stehouwer, CDA; Vd Waarenburg, M | 1 |
2 other study(ies) available for glyoxal and angiotensin ii
| Article | Year |
|---|---|
Amplification of AngII-dependent cell contraction by glyoxal: implication of cell mechanical properties and actomyosin activity.
Topics: Actin Cytoskeleton; Actomyosin; Amides; Angiotensin II; Glycation End Products, Advanced; Glyoxal; HEK293 Cells; Humans; Microscopy, Atomic Force; Microscopy, Fluorescence; Myosin Light Chains; Phosphorylation; Pyridines | 2014 |
Serum levels of autoantibodies against the angiotensin II type I receptor are not associated with serum dicarbonyl or AGE levels in patients with an aldosterone-producing adenoma.
Topics: Adenoma; Aldosterone; Angiotensin II; Autoantibodies; Chromatography, Liquid; Glycation End Products, Advanced; Glyoxal; Humans; Inflammation; Magnesium Oxide; Pyruvaldehyde; Receptor, Angiotensin, Type 1; Tandem Mass Spectrometry | 2023 |